Regencell Bioscience Holdings Ltd. is a early-stage bioscience company that focuses on research, development and commercialization of Traditional Chinese Medicine for the treatment of neurocognitive disorders and degeneration, specifically Attention Deficit Hyperactivity Disorder and Autism Spectrum Disorder. The company employs 10 full-time employees The company went IPO on 2021-07-16. The firm launches three liquid based standardized TCM formulae candidates for mild, moderate and severe ADHD and ASD patients.
RGC stock price ended at $6.09 on 星期二, after dropping 1.62%
On the latest trading day Jun 30, 2026, the stock price of RGC fell by 1.62%, dropping from $6.01 to $6.09. During the session, the stock saw a volatility of 18.62%, with prices oscillating between a daily low of $5.80 and a high of $6.88. On the latest trading day, the trading volume for RGC rose by 41.4K shares, despite the declining prices. This uptick in volume may signal heightened risk in the near term. In total, 441.4K shares were traded, with a market value of approximately $3.0B.
Teknik analiz göstergeleri RGC için nasıl uygulanır?
Teknik analize göre, Regencell Bioscience Holdings Ltd Sell toplam sinyaline sahiptir. Regencell Bioscience Holdings Ltd 2 adet al sinyali, 0 adet nötr sinyal ve 5 adet sat sinyali vardır.
RGC için Fibonacci geri dönüş seviyeleri nelerdir?
Regencell Bioscience Holdings Ltd için Fibonacci geri dönüş seviyesi 低于100%的水平dir。
Regencell Bioscience Holdings Ltd için RSI nedir?
Regencell Bioscience Holdings Ltd için mevcut RSI 7.98 'dir, bu da 超卖 durumunu gösterir
Önümüzdeki 12 ay için Regencell Bioscience Holdings Ltd fiyatı nedir?
Regencell Bioscience Holdings Ltd RGC önümüzdeki 12 ay için $0 olarak tahmin edilmektedir.
Regencell Bioscience Holdings Ltd ne kadar yükselmesi bekleniyor?
Wall Street analistlerine göre, Regencell Bioscience Holdings Ltd $0 yüksek tahminine ulaşması beklenmektedir.